购物车
- 全部删除
- 您的购物车当前为空
Befotertinib (D-0316) mesylate, a third-generation EGFR tyrosine kinase inhibitor, is utilized in research focused on EGFR T790M-positive non-small cell lung cancer (NSCLC) [1].
Befotertinib (D-0316) mesylate, a third-generation EGFR tyrosine kinase inhibitor, is utilized in research focused on EGFR T790M-positive non-small cell lung cancer (NSCLC) [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Befotertinib (D-0316) mesylate, a third-generation EGFR tyrosine kinase inhibitor, is utilized in research focused on EGFR T790M-positive non-small cell lung cancer (NSCLC) [1]. |
别名 | D-0316 mesylate |
分子量 | 663.71 |
分子式 | C30H36F3N7O5S |
CAS No. | 2226167-02-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容